Riki Okita, Nobutaka Kawamoto, Masanori Okada, Hidetoshi Inokawa, Naoki Yamamoto, Tomoyuki Murakami, Eiji Ikeda. Preoperative neutrophil-to-lymphocyte ratio correlates with PD-L1 expression in immune cells of patients with malignant pleural mesothelioma and predicts prognosis. Scientific Reports. 2023. 13. 1
Riki Okita, Nobutaka Kawamoto, Masanori Okada, Hidetoshi Inokawa, Naoki Yamamoto, Tomoyuki Murakami, Eiji Ikeda. Preoperative neutrophil-to-lymphocyte ratio correlates with PD-L1 expression in immune cells of patients with malignant pleural mesothelioma and predicts prognosis. Scientific reports. 2023. 13. 1. 5263-5263
Riki Okita, Yuka Mimura-Kimura, Nobutaka Kawamoto, Naoki Yamamoto, Masashi Umeda, Masanori Okada, Hidetoshi Inokawa, Yusuke Mimura, Tomoyuki Murakami, Masao Nakata, et al. Effects of tumor-infiltrating CD8+ T cells, PD1/PD-L1 axis, and expression patterns of HLA class I on the prognosis of patients with malignant pleural mesothelioma who underwent extra-pleural pneumonectomy. Cancer immunology, immunotherapy : CII. 2022
Nobutaka Kawamoto, Riki Okita, Masanori Okada, Kosuke Ito, Katsutoshi Hirazawa, Hidetoshi Inokawa. Fibrin glue-induced eosinophilic pleural effusion after pulmonary resection: A case report. International Journal of Surgery Case Reports. 2021. 85
R. Okita, A. Maeda, T. Yukawa, K. Shimizu, Y. Nojima, S. Saisho, M. Nakata. Survival of non-small cell lung cancer patients predicted from expression of PD-L1, HLA class I and MICA/B on tumor cells. ANNALS OF ONCOLOGY. 2017. 28
Yuji Nojima, Katsuhiko Shimizu, Ai Maeda, Shinsuke Saisho, Riki Okita, Masao Nakata. Clinicopathological and Immunohistochemical Features in Lung Invasive Mutinous Adenocarcinoma According to Computed Tomography Findings. JOURNAL OF THORACIC ONCOLOGY. 2017. 12. 1. S1123-S1123
R. Okita, Y. Nojima, A. Maeda, S. Saisho, K. Shimizu, M. Nakata. Repeated exposure to cisplatin enhances NK cell-mediated cytotoxicity via up-regulation of NKG2D ligands in non-small cell lung cancer cells. ANNALS OF ONCOLOGY. 2016. 27
R. Okita, T. Yukawa, Y. Nojima, A. Maeda, S. Saisho, K. Shimizu, M. Nakata. Overexpression of NK cell-activating ligand MICA/B correlates with superior outcomes and might be a therapeutic target for chemo-immunotherapy in non-small-cell lung cancer. ANNALS OF ONCOLOGY. 2015. 26. 149-150
2018/04 - 現在 NHO Yamaguchi Ube Medical Center Thoracic Surgery chief physician
2012/04 - 2018/03 Kawasaki Medical School General Thoracic Surgery
2009/05 - 2012/03 Karolinska Institutet Oncology-Pathology post doc
2008/04 - 2009/04 Hiroshima Univ. Research Institute for Radiation Biology and Medicine Surgical Oncology Assistant professor
2007/10 - 2008/03 広島大学 がん治療学 特任助教
2005/04 - 2007/09 Hiroshima University Research Institute for Radiation Biology and Medicine
2004/04 - 2005/03 医療法人 錦病院 非常勤医師
2001/04 - 2004/03 国立病院機構四国がんセンター 外科 レジデント
1999/04 - 2001/03 広島市立安佐市民病院 外科 医員
1998/05 - 1999/03 Hiroshima University Research Institute for Radiation Biology and Medicine
Show all
Awards (1):
2006/12 - 日本バイオセラピィ学会 優秀演題賞
Association Membership(s) (8):
日本乳癌学会
, THE JAPAN LUNG CANCER SOCIETY
, JAPAN SOCIETY OF CLINICAL ONCOLOGY
, ESMO
, JSMO
, THE JAPANESE ASSOCIATION FOR THORACIC SURGERY
, THE JAPANESE ASSOCIATION FOR CHEST SURGERY
, JAPAN SURGICAL SOCIETY